Lexicon Pharma (LXRX) Reports Q4 EPS of $0.76
Tweet
Share
E-mailGet Alerts LXRX Hot Sheet
Price: $2.32 -0.85%
EPS Growth %: -600.0%
Financial Fact:
Loss from operations: -34.93M
Today's EPS Names:
CRMT, More
EPS Growth %: -600.0%
Financial Fact:
Loss from operations: -34.93M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q4 EPS of $0.76, versus ($0.03) reported last year. Revenue for the quarter came in at $127.3 million, versus $21.5 million reported last year.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Six Flags names Mark Pauls as chief operating officer
- Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
